UPDATE - Media Advisory - Minister of Transport to make an announcement on passenger rail services in Brantford
BRANTFORD, ON, Aug. 5, 2021 /CNW/ - The Minister of Transport, the Honourable Omar Alghabra, and Mayor Designate and City Councillor of the City of Brantford, Mr. John Utley, will make an announcement on passenger rail services in Southwestern Ontario.
Minister Alghabra and Mayor Designate Utley will be available to answer questions from the media following the announcement.
For media participation on-site:
In line with the Public Health Agency of Canada and Public Health Ontario health measures, advice and restrictions, in-person attendance will be controlled by Transport Canada. Official photo identification must be presented at registration. Wearing a face cover is mandatory.
We ask people who have recently received a positive diagnosis for COVID-19, or are awaiting test results, or who have been exposed to COVID-19, or are experiencing symptoms as described on Health Canada's website, not to attend.
Carbon Streaming Corporation (Cboe CA: NETZ) ("Carbon Streaming" or the "Company") provides an update on the Rimba Raya Project ("Rimba Raya" or the "Project"). The Company has learned of two third-party media reports that claim PT Rimba Raya...
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...
The "Indonesia Construction Equipment Rental Market - Strategic Assessment & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.
The Indonesia construction equipment rental market was valued at $474.1 in 2023 and is...
MastercardBy Vicki HymanPhilanthropist Melinda French Gates, right, spoke with Rosario Dawson, an actor and activist for gender equality, left, and Fatoumata Bâ, center, the founder and executive chair of Janngo Capital, about how to close the...
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor...
